Company Information

Revenue, expenses and profitability over five years.

Income Statement

BROOKS LABORATORIES LTD.

NSE Code: BROOKSEQ
BSE Code: 533543
ISIN: INE650L01011
Industry: Pharmaceuticals

Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24
Months	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR
FaceValue	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	85.38	82.19	79.01
Other Operating Revenues	0.36	0.37	0.47
Total Operating Revenues	85.74	82.56	79.49

Other Income	1.17	0.88	0.96
Total Revenue	86.91	83.44	80.44

EXPENSES
Cost Of Materials Consumed	49.61	47.04	44.72
Purchase Of Stock-In Trade	2.25	7.18	10.50
Operating And Direct Expenses	0.00	5.29	4.44
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.84	-0.15	1.40
Employee Benefit Expenses	15.16	12.96	10.54
Finance Costs	0.84	1.03	0.84
Depreciation And Amortisation Expenses	1.59	1.60	1.77
Other Expenses	12.49	5.26	4.67
Total Expenses	81.10	80.21	78.89

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.81	3.23	1.55

Profit/Loss Before Tax	5.81	3.23	1.55

Tax Expenses-Continued Operations
Tax For Earlier Years	0.00	0.18	0.03
Total Tax Expenses	0.00	0.18	0.03
Profit/Loss After Tax And Before ExtraOrdinary Items	5.81	3.05	1.53

Profit/Loss From Continuing Operations	5.81	3.05	1.53

Profit/Loss For The Period	5.81	3.05	1.53

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	1.97	1.14	0.58
Diluted EPS (Rs.)	1.97	1.14	0.58

Five-year consolidated Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	85.38	82.19	79.01	63.20	91.08
Other Operating Revenues	0.36	0.37	0.47	0.00	0.00
Total Operating Revenues	85.74	82.56	79.49	63.20	91.08

Other Income	1.17	0.88	0.96	0.20	0.91
Total Revenue	86.91	83.44	80.44	63.41	91.99

EXPENSES
Cost Of Materials Consumed	49.61	47.04	44.72	41.55	62.93
Purchase Of Stock-In Trade	2.25	7.18	10.50	4.87	1.96
Operating And Direct Expenses	0.00	5.29	4.44	7.13	9.51
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.84	-0.15	1.40	4.18	-2.10
Employee Benefit Expenses	15.16	12.96	10.54	17.34	19.15
Finance Costs	0.84	1.03	0.84	2.18	3.10
Depreciation And Amortisation Expenses	1.59	1.60	1.77	7.03	7.35
Other Expenses	12.49	5.30	4.67	14.55	13.99
Total Expenses	81.10	80.25	78.89	98.83	115.88

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.81	3.19	1.55	-35.42	-23.90

Exceptional Items	0.00	0.00	0.00	0.36	0.00
Profit/Loss Before Tax	5.81	3.19	1.55	-35.07	-23.90

Tax Expenses-Continued Operations
Deferred Tax	0.00	0.00	0.00	-7.32	-4.59
Tax For Earlier Years	0.00	0.18	0.03	0.00	0.00
Total Tax Expenses	0.00	0.18	0.03	-7.32	-4.59
Profit/Loss After Tax And Before ExtraOrdinary Items	5.81	3.02	1.53	-27.74	-19.31

Profit/Loss From Continuing Operations	5.81	3.02	1.53	-27.74	-19.31

Profit/Loss For The Period	5.81	3.02	1.53	-27.74	-19.31

Minority Interest	0.00	0.00	0.00	10.15	3.13
Share Of Profit/Loss Of Associates	18.78	-12.98	-21.12	-3.31	0.00
Consolidated Profit/Loss After MI And Associates	24.58	-9.97	-19.59	-20.90	-16.19

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	8.35	-3.72	-7.65	-12.57	-7.82
Diluted EPS (Rs.)	8.35	-3.72	-7.65	-12.57	-7.82

Source: Financial statements as reported by the company.